Bionano Genomics Announces Release Of Version 6.2 Of NxClinical Software With New Capabilities For Cancer Research Applications Including HRD Analysis
Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of NxClinical™ software, the leading solution for visualization, interpretation and
Bionano Genomics’s Return On Capital Employed Insights
Benzinga Pro data, Bionano Genomics (NASDAQ:BNGO) reported Q4 sales of $6.30 million. Earnings fell to a loss of $22.95 million, resulting in a 10.58% decrease from last quarter.
Bionano Genomics Q4 Sales $6.30M Beat $5.57M Estimate
Bionano Genomics (NASDAQ:BNGO) reported quarterly sales of $6.30 million which beat the analyst consensus estimate of $5.57 million by 13.11 percent. This is a 57.89 percent increase over sales of $3.99 million the same
Top 10 Trending Penny Stocks for Friday, Jan. 28, 2022 (Sentiment via Swaggy Stocks)
Zomedica (ZOM)
Bright Minds Biosciences (DRUG)
Exicure (XCUR)
Vinco Ventures (BBIG)
Bionano Genomics (BNGO)
BioPlus Acquisition (BIOS)
Via Renewables (VIA)
Bowlero (BOWL)
Exela Technologies (XELA)
Farmmi
Bionano Genomics Preliminary Q4, FY21 Revenue Exceed Expectations
Bionano Genomics Inc (NASDAQ: BNGO)
‘Why Bionano Stock Is ‘Underappreciated,’ According to Oppenheimer’ -TipRanks
https://www.tipranks.com/news/article/why-bionano-stock-is-underappreciated-according-to-oppenheimer/
Bionano Genomics Announces Publication Of Study Evaluating Optical Genome Mapping For High Throughput Characterization Of Cytogenomic Heterogeneity In MDS
Bionano Genomics, Inc. (BNGO), provider of optical genome mapping (OGM) solutions on the Saphyr® system and the leading software for genomic data visualization, interpretation and reporting, today announced the
5 Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.